PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITY

Overview

INTRODUCTION: Breast cancer is one of the pathologies affecting women worldwide, with a high mortality rate of 14,206 per 100,000 women per year. However, Pilates was used as a therapeutic treatment for women who underwent a modified radical mastectomy, being associated with the alterations when in the postoperative sequels. OBJECTIVE: to evaluate the Pilates Method in the functionality of women submitted to modified radical mastectomy. METHOD: This is a quantitative clinical trial, in the form of women included in the project, to undergo a physical therapy rehabilitation program through the Pilates Method for 2 months, where they were evaluated before and after the procedure for measurement and comparison obtained. CONCLUSION: In this way, the pilates method is presented as an instrument used for the rehabilitation of mastectomized women.

Full Title of Study: “PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITY OF THE MASTECTOMIZED WOMEN”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 1, 2018

Interventions

  • Other: Pliates method treatment
    • The participants undergo to a physical therapy rehabilitation program through the Pilates Method for 2 months.

Arms, Groups and Cohorts

  • Experimental: Pilates treatment
    • The participants undergo to a physical therapy rehabilitation program through the Pilates Method for 2 months.

Clinical Trial Outcome Measures

Primary Measures

  • Muscle strength
    • Time Frame: 2 months
    • Medical Research Council scale for muscle power
  • Range of motion
    • Time Frame: 2 months
    • Range of motion evaluation by goniometry
  • Functionality assess with Functional independence measure scale
    • Time Frame: 2 months
    • Functional independence measure scale

Participating in This Clinical Trial

Inclusion Criteria

  • Female subjects, between 30 and 65 years, with a diagnosis of breast cancer, who underwent radical-mastectomy surgery and who had after 30 postoperative days Exclusion Criteria:

  • Women who present alterations in healing, severe pain, who have another type of treatment, people who lack more than three times in the research, quitters, people with relapses and who do not tolerate the treatment protocol.

Gender Eligibility: Female

women in post-operative radical-mastectomy treatment.

Minimum Age: 30 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Universidade Metodista de Piracicaba
  • Provider of Information About this Clinical Study
    • Principal Investigator: Raphael do Nascimento Pereira, Raphael do Nascimento Pereira – Universidade Metodista de Piracicaba

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.